Showing results (171-180 of 367) with videos related to

Sort By:
Pageof 37
JACC. Heart Failure|July 30, 2021
Patient Phenotypes and SGLT-2 Inhibition in Type 2 Diabetes: Insights From the EMPA-REG OUTCOME TrialAbhinav Sharma, Anne Pernille Ofstad, Tariq Ahmad, et al.
European Heart Journal|January 29, 2016
Heart failure outcomes with empagliflozin in patients with type 2 diabetes at high cardiovascular risk: results of the EMPA-REG OUTCOME® trialDavid Fitchett, Bernard Zinman, Christoph Wanner, et al.
Circulation|September 15, 2017
Empagliflozin and Clinical Outcomes in Patients With Type 2 Diabetes Mellitus, Established Cardiovascular Disease, and Chronic Kidney DiseaseChristoph Wanner, John M Lachin, Silvio E Inzucchi, et al.
The Canadian Journal of Cardiology|February 25, 2018
The State of Cardiovascular Magnetic Resonance Imaging in Canada: Results from the CanSCMR Pan-Canadian SurveyIdan Roifman, D Ian Paterson, Laura Jimenez-Juan, et al.
Heart Rhythm|February 21, 2012
N-3 polyunsaturated fatty acid supplementation does not reduce vulnerability to atrial fibrillation in remodeling atriaAndrew Ramadeen, Kim A Connelly, Howard Leong-Poi, et al.
The American Journal of Cardiology|November 10, 2010
Relation between hemoglobin level and recurrent myocardial ischemia in acute coronary syndromes detected by continuous electrocardiographic monitoringMelissa Rousseau, Raymond T Yan, Mary Tan, et al.
ESC Heart Failure|April 11, 2023
IGFBP7 and left ventricular mass regression: a sub-analysis of the EMPA-HEART CardioLink-6 randomized clinical trialPankaj Puar, Nikhil Mistry, Kim A Connelly, et al.
Nephron Extra|June 29, 2012
Hyperglycemia and renal mass ablation synergistically augment albuminuria in the diabetic subtotally nephrectomized rat: implications for modeling diabetic nephropathyLi-Hao Chen, Bailey Stead, Suzanne L Advani, et al.
Clinical Cardiology|June 24, 2022
Stage-based approach to predict left ventricular reverse remodeling after mitral repairMakoto Hibino, Nitish K Dhingra, Vincent Chan, et al.
Current Opinion in Cardiology|July 23, 2020
Sodium-glucose cotransporter 2 inhibitors at the intersection of cardiovascular, renal and metabolic care: an integrated and multidisciplinary approach to patient-centered careSubodh Verma, Eric Klug, Viacheslav Y Mareev, et al.
Pageof 37